In St. Paul, Minnesota, long winters and limited specialist access can make weight management harder than it should be. Rybelsus® is the FDA-approved Oral tablet Semaglutide product manufactured by Novo Nordisk since 2019. Weight Method offers a separate option: licensed Minnesota providers evaluate eligible patients via telehealth and prescribe compounded Semaglutide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Semaglutide is not FDA-approved. The Weight Method program for St. Paul starts at $199/month — medication, provider evaluation, ongoing care, and shipping included.
GLP-1 treatment prescribed by licensed providers. Delivered to your door.
Free consultation · No commitment · Results in weeks
From 2,000+ patients · St. Paul is already seeing results
GLP-1 weight-loss treatment available to eligible patients in St. Paul, MN. Weight Method offers compounded semaglutide, prescribed by licensed providers, from $199/month with virtual consultations and direct-to-door shipping.
Semaglutide targets the biological mechanisms involved in sustained weight regulation. By activating GLP-1 receptors in the brain, it can reduce hunger signals and slow gastric emptying. Novo Nordisk developed Rybelsus® as the FDA-approved Oral tablet product, taken Once daily, approved in 2019. Weight Method is a separate program: licensed providers in Minnesota evaluate eligible patients via telehealth and prescribe compounded Semaglutide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Semaglutide is not FDA-approved. The Weight Method program for eligible St. Paul, MN residents starts at $199/month.
Urban residents in St. Paul are often surrounded by healthcare options yet still struggle to access GLP-1 treatment. Primary care physicians may not specialize in GLP-1 prescribing, and specialist clinics charge $500+ per visit. Weight Method's all-inclusive compounded Semaglutide program — consultation, medication, and ongoing support at $199/month — is built for the urban patient who values quality and efficiency. Compounded Semaglutide is dispensed by a U.S.-licensed 503A pharmacy and is not FDA-approved.
Compounded GLP-1 medications dispensed by U.S.-licensed 503A pharmacies.

Compounded semaglutide. Once-weekly subcutaneous injection.

Compounded tirzepatide. Dual-action GLP-1/GIP, once-weekly subcutaneous injection.
Consult with a licensed provider in Minnesota and start Rybelsus from $199/month.
Get Started NowFree consultation. No commitment.